KYNB KYNTRA BIO, INC.

$8.50 -0.53%

Updated 17 d ago

Healthcare · Pharmaceutical Preparations

KYNTRA BIO, INC. (KYNB) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $34 million. Shares last traded at $8.50, 11.0% below their 52-week high. KYNB trades at a price-to-earnings ratio of 0.19, below the Pharmaceutical Preparations median of 17.31. Revenue declined 78.3% year over year.

Market Cap

$34M

Shares Out

4.0M

EPS (TTM)

$43.61

P/E Ratio

0.19

P/S Ratio

7.45

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$9.55

52-Week Low

$6.45

Volume

243

Avg Vol (3m)

347.27

Performance

+5.72%

+21.60%

+8.14%

YTD

-10.53%

—

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

70.04

SMA (50)

$7.32

SMA (200)

—

Price vs SMA50

+16.16%

Price vs SMA200

—

ATR (14)

$0.25

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$5M

Net Income

$183M

Gross Margin

6.3%

Operating Margin

—

Net Margin

—

Return on Equity

-607.7%

Return on Assets

181.2%

Current Ratio

2.69

Debt / Equity

-2.49

Revenue Growth (YoY)

-78.3%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.80	2026-08-13
Q1 2026	$-3.76	2026-05-12
FY 2025	$45.37	2026-03-16
Q3 2025	$48.90	2025-11-10
Q2 2026	$-0.73	2026-08-13
Q1 2026	$1.15	2026-05-12

Full earnings history →

Pharmaceutical Preparations peers

KYNB vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 17 d ago

P/E vs peers

0.19 / 17.31 med

-99% discount

P/S vs peers

7.45 / 11.11 med

-33% discount

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.